CEimpact Podcast
The CEimpact Podcast features two shows:
GameChangers Clinical Updates
Precept2Practice
GameChangers Clinical Update Series:
The GameChangers podcast, hosted by Rachel Maynard, PharmD, features the latest game-changing pharmacotherapy advances impacting patient care. New episodes arrive every Monday. Listeners can purchase the episode to earn CE credit at: https://www.ceimpact.com/resources/podcast/
Precept2Practice
The Precept2Practice podcast, hosted by Kathy Schott, brings you tools to mentor students and residents with confidence. New episodes arrive on the third Wednesday of every month. Preceptor By Design™ subscribers can earn CE credit for each episode.
Give us a follow, tune in regularly, and turn your drive time, coffee break, or chart review into a chance to level up your practice. CEimpact continuing education makes pharmacy learning inspiring!
Check back each week for our latest episodes.
CEimpact Podcast
Just One More Inhaler for Asthma
New asthma guidelines came out in 2020, yet the answer to triple or dual inhaler therapy wasn't explicitly answered. In this episode host, Geoff Wall and guest, Jake Galdo discuss the role of triple inhaler (ICS-LABA-LAMA) in the management of severe persistent and uncontrolled asthma.
Redeem your CPE or CME credit with a GameChangers Subscription here!
We want your feedback! Share your feedback and experience with GameChangers! https://www.jotform.com/build/90155144694964
References and resources:
Kim LHY, Saleh C, Whalen-Browne A, et al. Triple vs Dual Inhaler Therapy and Asthma Outcomes in Moderate to Severe Asthma: A Systematic Review and Meta-analysis. JAMA. 2021 May 19:e217872. doi: 10.1001/jama.2021.7872. Epub ahead of print. PMID: 34009257; PMCID: PMC8135065.
Continuing Education Information:
Learning Objectives:
1. Discuss a recent study comparing triple to dual inhaler therapy in asthma
2. Describe the adverse drug events associated with triple inhaler therapy in asthma
0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-21-230-H01-P
Initial release date: 7/13/21
Expiration date: 7/13/22
Complete CPE & CME details can be found here.